195 related articles for article (PubMed ID: 21520340)
1. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.
Higaki K; Li L; Bahrudin U; Okuzawa S; Takamuram A; Yamamoto K; Adachi K; Paraguison RC; Takai T; Ikehata H; Tominaga L; Hisatome I; Iida M; Ogawa S; Matsuda J; Ninomiya H; Sakakibara Y; Ohno K; Suzuki Y; Nanba E
Hum Mutat; 2011 Jul; 32(7):843-52. PubMed ID: 21520340
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast screening for chaperone therapy in beta-galactosidosis.
Iwasaki H; Watanabe H; Iida M; Ogawa S; Tabe M; Higaki K; Nanba E; Suzuki Y
Brain Dev; 2006 Sep; 28(8):482-6. PubMed ID: 16617000
[TBL] [Abstract][Full Text] [Related]
3. Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.
Matsuda J; Suzuki O; Oshima A; Yamamoto Y; Noguchi A; Takimoto K; Itoh M; Matsuzaki Y; Yasuda Y; Ogawa S; Sakata Y; Nanba E; Higaki K; Ogawa Y; Tominaga L; Ohno K; Iwasaki H; Watanabe H; Brady RO; Suzuki Y
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15912-7. PubMed ID: 14676316
[TBL] [Abstract][Full Text] [Related]
4. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
Suzuki Y
Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
[TBL] [Abstract][Full Text] [Related]
5. Chemical chaperone treatment for galactosialidosis: Effect of NOEV on β-galactosidase activities in fibroblasts.
Hossain MA; Higaki K; Shinpo M; Nanba E; Suzuki Y; Ozono K; Sakai N
Brain Dev; 2016 Feb; 38(2):175-80. PubMed ID: 26259553
[TBL] [Abstract][Full Text] [Related]
6. Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis.
Suzuki Y; Ichinomiya S; Kurosawa M; Ohkubo M; Watanabe H; Iwasaki H; Matsuda J; Noguchi Y; Takimoto K; Itoh M; Tabe M; Iida M; Kubo T; Ogawa S; Nanba E; Higaki K; Ohno K; Brady RO
Ann Neurol; 2007 Dec; 62(6):671-5. PubMed ID: 17994547
[TBL] [Abstract][Full Text] [Related]
7. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.
Caciotti A; Donati MA; d'Azzo A; Salvioli R; Guerrini R; Zammarchi E; Morrone A
Eur J Paediatr Neurol; 2009 Mar; 13(2):160-4. PubMed ID: 18571950
[TBL] [Abstract][Full Text] [Related]
8. Beta-galactosidase deficiency: an approach to chaperone therapy.
Suzuki Y
J Inherit Metab Dis; 2006; 29(2-3):471-6. PubMed ID: 16763919
[TBL] [Abstract][Full Text] [Related]
9. Chemical chaperone therapy: luciferase assay for screening of β-galactosidase mutations.
Li L; Higaki K; Ninomiya H; Luan Z; Iida M; Ogawa S; Suzuki Y; Ohno K; Nanba E
Mol Genet Metab; 2010 Dec; 101(4):364-9. PubMed ID: 20826101
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic chaperone effect of N-octyl 4-epi-β-valienamine on murine G(M1)-gangliosidosis.
Suzuki Y; Ichinomiya S; Kurosawa M; Matsuda J; Ogawa S; Iida M; Kubo T; Tabe M; Itoh M; Higaki K; Nanba E; Ohno K
Mol Genet Metab; 2012 May; 106(1):92-8. PubMed ID: 22436580
[TBL] [Abstract][Full Text] [Related]
11. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies.
Santamaria R; Chabás A; Coll MJ; Miranda CS; Vilageliu L; Grinberg D
Hum Mutat; 2006 Oct; 27(10):1060. PubMed ID: 16941474
[TBL] [Abstract][Full Text] [Related]
12. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
[TBL] [Abstract][Full Text] [Related]
13. GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.
Hofer D; Paul K; Fantur K; Beck M; Bürger F; Caillaud C; Fumic K; Ledvinova J; Lugowska A; Michelakakis H; Radeva B; Ramaswami U; Plecko B; Paschke E
Hum Mutat; 2009 Aug; 30(8):1214-21. PubMed ID: 19472408
[TBL] [Abstract][Full Text] [Related]
14. Chemical chaperone therapy for GM1-gangliosidosis.
Suzuki Y
Cell Mol Life Sci; 2008 Feb; 65(3):351-3. PubMed ID: 18202827
[TBL] [Abstract][Full Text] [Related]
15. DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.
Fantur K; Hofer D; Schitter G; Steiner AJ; Pabst BM; Wrodnigg TM; Stütz AE; Paschke E
Mol Genet Metab; 2010 Jul; 100(3):262-8. PubMed ID: 20409738
[TBL] [Abstract][Full Text] [Related]
16. [beta-galactosidosis--GM1 gangliosidosis and Morquio B disease].
Yoshida K; Yanagisawa N
Nihon Rinsho; 1995 Dec; 53(12):2960-6. PubMed ID: 8577043
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
Takamura A; Higaki K; Ninomiya H; Takai T; Matsuda J; Iida M; Ohno K; Suzuki Y; Nanba E
J Neurochem; 2011 Aug; 118(3):399-406. PubMed ID: 21574998
[TBL] [Abstract][Full Text] [Related]
18. Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis.
Caciotti A; Donati MA; Boneh A; d'Azzo A; Federico A; Parini R; Antuzzi D; Bardelli T; Nosi D; Kimonis V; Zammarchi E; Morrone A
Hum Mutat; 2005 Mar; 25(3):285-92. PubMed ID: 15714521
[TBL] [Abstract][Full Text] [Related]
19. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
Hinek A; Zhang S; Smith AC; Callahan JW
Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
[TBL] [Abstract][Full Text] [Related]
20. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
